Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Calandra

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Pediatric Clinics of North America|June 1, 1990
Vaccination of infants and children against hepatitis BD J West, G B Calandra, R W Ellis
The Journal of Antimicrobial Chemotherapy|December 1, 1986
The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patientsG B Calandra, C Wang, M Aziz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of selected infections of the skin and skin structure. Infectious Diseases Society of America and the Food and Drug AdministrationG B Calandra, C Norden, J D Nelson, et al.
Arthritis and Rheumatism|April 1, 1983
Sex hormonal effects on the severity of streptococcal cell wall-induced polyarthritis in the ratJ B Allen, D Blatter, G B Calandra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of osteomyelitis in adults. Infectious Diseases Society of America and the Food and Drug AdministrationJ T Mader, C Norden, J D Nelson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of acute hematogenous osteomyelitis in children. Infectious Diseases Society of America and the Food and Drug AdministrationJ D Nelson, C Norden, J T Mader, et al.
Journal of Clinical Pharmacology|February 1, 1988
The efficacy results and safety profile of imipenem/cilastatin from the clinical research trialsG B Calandra, F M Ricci, C Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of acute suppurative arthritis in children. Infectious Diseases Society of America and the Food and Drug AdministrationJ D Nelson, C Norden, J T Mader, et al.
Reviews of Infectious Diseases|July 1, 1985
Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experienceC Wang, G B Calandra, M A Aziz, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1983
Safety and tolerance comparison of imipenem-cilastatin to cephalothin and cefazolinG B Calandra, F M Ricci, C Wang, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Pediatric Clinics of North America|June 1, 1990
Vaccination of infants and children against hepatitis BD J West, G B Calandra, R W Ellis
The Journal of Antimicrobial Chemotherapy|December 1, 1986
The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patientsG B Calandra, C Wang, M Aziz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of selected infections of the skin and skin structure. Infectious Diseases Society of America and the Food and Drug AdministrationG B Calandra, C Norden, J D Nelson, et al.
Arthritis and Rheumatism|April 1, 1983
Sex hormonal effects on the severity of streptococcal cell wall-induced polyarthritis in the ratJ B Allen, D Blatter, G B Calandra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of osteomyelitis in adults. Infectious Diseases Society of America and the Food and Drug AdministrationJ T Mader, C Norden, J D Nelson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of acute hematogenous osteomyelitis in children. Infectious Diseases Society of America and the Food and Drug AdministrationJ D Nelson, C Norden, J T Mader, et al.
Journal of Clinical Pharmacology|February 1, 1988
The efficacy results and safety profile of imipenem/cilastatin from the clinical research trialsG B Calandra, F M Ricci, C Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of acute suppurative arthritis in children. Infectious Diseases Society of America and the Food and Drug AdministrationJ D Nelson, C Norden, J T Mader, et al.
Reviews of Infectious Diseases|July 1, 1985
Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experienceC Wang, G B Calandra, M A Aziz, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1983
Safety and tolerance comparison of imipenem-cilastatin to cephalothin and cefazolinG B Calandra, F M Ricci, C Wang, et al.
Pageof 6